Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase

被引:368
作者
Loeffler, JM [1 ]
Nelson, D [1 ]
Fischetti, VA [1 ]
机构
[1] Rockefeller Univ, Lab Bacterial Pathogenesis, New York, NY 10021 USA
关键词
D O I
10.1126/science.1066869
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nasopharyngeal carriage is the major reservoir for Streptococcus pneumoniae in the community. Although eliminating this reservoir would greatly reduce disease occurrence, no suitable intervention has been available for this purpose. We show here that seconds after contact, a purified pneumococcal bacteriophage lytic enzyme (Pal) is able to kill 15 common serotypes of pneumococci, including highly penicillin-resistant strains. In vivo, previously colonized mice revealed undetectable pneumococcal titers 5 hours after a single enzyme treatment. Pal enzyme had little or no effect on microorganisms normally found in the human oropharynx, and Pal-resistant pneumococci could not be detected after extensive exposure to the enzyme.
引用
收藏
页码:2170 / 2172
页数:3
相关论文
共 18 条
[1]   A protein antibiotic in the phage Qβ virion:: Diversity in lysis targets [J].
Bernhardt, TG ;
Wang, IN ;
Struck, DK ;
Young, R .
SCIENCE, 2001, 292 (5525) :2326-2329
[2]   Bacteriophages of Streptococcus pneumoniae: A molecular approach [J].
Garcia, P ;
Martin, AC ;
Lopez, R .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :165-176
[3]   SPECIES OF ALPHA-HEMOLYTIC STREPTOCOCCI POSSESSING A C-POLYSACCHARIDE PHOSPHORYLCHOLINE-CONTAINING ANTIGEN [J].
GILLESPIE, SH ;
MCWHINNEY, PHM ;
PATEL, S ;
RAYNES, JG ;
MCADAM, KPW ;
WHILEY, RA ;
HARDIE, JM .
INFECTION AND IMMUNITY, 1993, 61 (07) :3076-3077
[4]   Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I [J].
Hausdorff, WP ;
Bryant, J ;
Paradiso, PR ;
Siber, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :100-121
[5]   The pneumococcal cell wall degrading enzymes: A modular design to create new lysins? [J].
Lopez, R ;
Garcia, E ;
Garcia, P ;
Garcia, JL .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :199-211
[6]   Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine [J].
Mbelle, N ;
Heubner, RE ;
Wasas, AD ;
Kimura, A ;
Chang, I ;
Klugman, KP .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :1171-1176
[7]   Long-circulating bacteriophage as antibacterial agents [J].
Merril, CR ;
Biswas, B ;
Carlton, R ;
Jensen, NC ;
Creed, GJ ;
Zullo, S ;
Adhya, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3188-3192
[8]   Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme [J].
Nelson, D ;
Loomis, L ;
Fischetti, VA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :4107-4112
[9]   Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge? [J].
Pelton, SI .
VACCINE, 2000, 19 :S96-S99
[10]   Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin [J].
Putnam, SD ;
Gray, GC ;
Biedenbach, DJ ;
Jones, RN .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (01) :2-8